What is the SHIPP-BIO study?

The SHIP-BIO study aims to evaluate biomarkers as an addition to clinical assessment in the emergency department in a scandinavian cohort of children 0-17 years affected by blunt mild-moderate traumatic brain injury. The study is recruiting patients at Halmstad hospital, Varberg hospital and Drottnings Silvia children´s hospital. 

Previous work

The SHIPP-study was a multicentre study in Scandinavia aiming to validate and develop the Scandinavian guidelines for initial management of minor and moderate head trauma in children

(Åstrand et al, 2016).

The guideline stratifies risk for clinically important intracranial injury after blunt head trauma in children, and management recommendations are based upon this risk stratification.

The study resulted in serveral publications

- Diagnostic accuracy of the Scandinavian guidelines for minor and moderate head trauma in children: a prospective, pragmatic, validation study

-Comparison of predictive tools for management of paediatric mild TBI: a prospective cohort study